ArticleExperimental brain research2026
Parkinson's disease dementia and hearing impairment, are they related? A UK biobank pilot analysis.
Article in Experimental brain research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Hearing impairment is implicated as a risk factor for the incidence of all-cause dementia. However, few studies have explored the relationship between hearing loss and specific rarer dementia subtypes. Therefore, this pilot study sought to explore whether hearing impairment, estimated using a speech-in-noise test (the digit triplet test, DTT), is a risk factor for Parkinson’s disease dementia (PDD) incidence. We conducted a pre-registered prospective cohort study using UK Biobank data from 158,686 individuals (72,015 males; 86,671 females), who underwent the DTT, and were free from PDD at the point of assessment. A Cox Proportional Hazard model, controlling for age, sex and educational attainment was conducted. Over a median follow-up of 8.93 years (SD = 2.29), 101 cases of incident PDD were observed. While the hazard ratio were in the direction of a positive relationship between baseline DTT and PDD incidence, imprecision in estimates leaves it uncertain as to whether risk was influenced by speech-reception-threshold (HR = 2.39, 95% CI: 0.75,7.63; p = .141), and findings should be treated as exploratory. An exploratory analysis, in which speech-reception-thresholds were categorised according to UK Biobank norms, showed that ‘insufficient’ (p = .024), but not ‘poor’ (p = .236) hearing increased PDD risk. The observed HR directionally aligns with the previously observed positive relationship between hearing loss and all-cause dementia incidence. However, further studies employing alternative datasets with more PDD cases are required to substantiate these findings. If further supported, these findings may have clinical and public health implications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.